Aridis Pharmaceuticals Inc (ARDS)

$0.00 0.00 (N/A)
Market Cap 5,000.00
Revenue (ttm) 3.09M
Net Income (ttm) -30.37M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -982.85%
Debt to Equity Ratio 0.00
Volume 280
Avg Vol 21,342
Day's Range N/A - N/A
Shares Out 53.32M
Stochastic %K 0%
Beta 44.97
Analysts Strong Buy
Price Target $2.00

Company Profile

Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, discovers and develops targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that has completed Phase III pivotal trials for the treatment of lung infections resulting from S. aureus alphatoxin, as well as developing AR-301 as an adjunctive therapy with SOC antibiotics to treat hospital acquir...

Industry: Biotechnology
Sector: Healthcare
Phone: 408 385 1742
Fax: 408 356 9548
Address:
983 University Avenue, Building B, Los Gatos, United States
PenkeInvesting
PenkeInvesting Jun. 28 at 5:10 AM
Fundamental analysis of $ARDS (Aridis Pharmaceuticals, Inc.) based on financial data and reported results. #ARDS #Aridis
0 · Reply
Shanenobody
Shanenobody Jun. 18 at 8:42 PM
$ARDS I wouldn't pay any attention to Buyout Bobby. Buyout Bobby thinks he has me blocked. Buyout Bobby wrote: "those articles don't mean much. They are published all the time." This is the first article posted on ARDS in a long, long time.
0 · Reply
BuyoutBobby
BuyoutBobby Jun. 17 at 7:54 PM
$ARDS there was a big trade today.
1 · Reply
Shanenobody
Shanenobody Jun. 14 at 5:56 PM
$ARDS Check the date at the bottom of this filing: https://www.sec.gov/Archives/edgar/data/1614067/000117266126002121/xslSCHEDULE_13G_X02/primary_doc.xml
0 · Reply
Shanenobody
Shanenobody Jun. 9 at 8:31 PM
$ARDS https://finance.yahoo.com/sectors/healthcare/articles/pneumonia-market-set-witness-robust-140100395.html
0 · Reply
Kess123
Kess123 May. 29 at 4:24 AM
$ARDS if you plan to sue, the window is closing: Filing a Civil Lawsuit (Securities Fraud) If you believe the company or its executives misled investors and you are looking to join or initiate a civil lawsuit to recover funds, the legal windows are much tighter. The 2-Year / 5-Year Rule: Under the Securities Exchange Act, civil lawsuits for securities fraud must be filed within 2 years after you discover the facts constituting the violation. The Statute of Repose: There is a hard legal cap of 5 years after the actual violation occurred, regardless of when you discovered the fraud. Once that 5-year mark hits, the liability is extinguished. Criminal Prosecution: For context, if the federal government (DOJ) pursues the company, they have a 6-year statute of limitations to bring criminal securities fraud charges.
1 · Reply
ChiefStockTraderJr
ChiefStockTraderJr May. 12 at 10:01 PM
$ARDS Anything new? Like an old ghost town around here. I can almost hear the squeaking doors moving in the wind. It sure blew away our money like tumbleweeds. Nothing left but a lonely empty shell now. Shoulda been. Coulda been. Woulda been. Hey, let's not kid ourselves, we were robbed like a Jessie James holdup. Make no bones about it.
1 · Reply
CNPPLC
CNPPLC May. 6 at 2:41 PM
$ARDS If the state filing is delinquent., the shareholders can takeover the company under state law and bring the OTC listing to full compliance.
1 · Reply
ChiefStockTraderJr
ChiefStockTraderJr May. 1 at 1:45 AM
$ARDS My smallest checking account has more money than the entire market cap of this stock. Who works there? Volunteers?
2 · Reply
ChiefStockTraderJr
ChiefStockTraderJr Apr. 29 at 5:07 AM
$ARDS I was really disappointed on how this stock played out. I expected it to be some short gold mine or something. A diamond in the rough. It turned out to be just a hard road apple.
1 · Reply
Latest News on ARDS
No data available.
PenkeInvesting
PenkeInvesting Jun. 28 at 5:10 AM
Fundamental analysis of $ARDS (Aridis Pharmaceuticals, Inc.) based on financial data and reported results. #ARDS #Aridis
0 · Reply
Shanenobody
Shanenobody Jun. 18 at 8:42 PM
$ARDS I wouldn't pay any attention to Buyout Bobby. Buyout Bobby thinks he has me blocked. Buyout Bobby wrote: "those articles don't mean much. They are published all the time." This is the first article posted on ARDS in a long, long time.
0 · Reply
BuyoutBobby
BuyoutBobby Jun. 17 at 7:54 PM
$ARDS there was a big trade today.
1 · Reply
Shanenobody
Shanenobody Jun. 14 at 5:56 PM
$ARDS Check the date at the bottom of this filing: https://www.sec.gov/Archives/edgar/data/1614067/000117266126002121/xslSCHEDULE_13G_X02/primary_doc.xml
0 · Reply
Shanenobody
Shanenobody Jun. 9 at 8:31 PM
$ARDS https://finance.yahoo.com/sectors/healthcare/articles/pneumonia-market-set-witness-robust-140100395.html
0 · Reply
Kess123
Kess123 May. 29 at 4:24 AM
$ARDS if you plan to sue, the window is closing: Filing a Civil Lawsuit (Securities Fraud) If you believe the company or its executives misled investors and you are looking to join or initiate a civil lawsuit to recover funds, the legal windows are much tighter. The 2-Year / 5-Year Rule: Under the Securities Exchange Act, civil lawsuits for securities fraud must be filed within 2 years after you discover the facts constituting the violation. The Statute of Repose: There is a hard legal cap of 5 years after the actual violation occurred, regardless of when you discovered the fraud. Once that 5-year mark hits, the liability is extinguished. Criminal Prosecution: For context, if the federal government (DOJ) pursues the company, they have a 6-year statute of limitations to bring criminal securities fraud charges.
1 · Reply
ChiefStockTraderJr
ChiefStockTraderJr May. 12 at 10:01 PM
$ARDS Anything new? Like an old ghost town around here. I can almost hear the squeaking doors moving in the wind. It sure blew away our money like tumbleweeds. Nothing left but a lonely empty shell now. Shoulda been. Coulda been. Woulda been. Hey, let's not kid ourselves, we were robbed like a Jessie James holdup. Make no bones about it.
1 · Reply
CNPPLC
CNPPLC May. 6 at 2:41 PM
$ARDS If the state filing is delinquent., the shareholders can takeover the company under state law and bring the OTC listing to full compliance.
1 · Reply
ChiefStockTraderJr
ChiefStockTraderJr May. 1 at 1:45 AM
$ARDS My smallest checking account has more money than the entire market cap of this stock. Who works there? Volunteers?
2 · Reply
ChiefStockTraderJr
ChiefStockTraderJr Apr. 29 at 5:07 AM
$ARDS I was really disappointed on how this stock played out. I expected it to be some short gold mine or something. A diamond in the rough. It turned out to be just a hard road apple.
1 · Reply
BuyoutBobby
BuyoutBobby Apr. 14 at 7:54 PM
$ARDS they published a news on their website. Maybe its not over yet.
1 · Reply
ChiefStockTraderJr
ChiefStockTraderJr Apr. 10 at 10:50 AM
$ARDS I bought this stock years ago and still holding on tho WORTHLESS shares. Has anyone heard any news on it? Anything? Is it completely dead?
1 · Reply
Bigos
Bigos Mar. 16 at 6:35 PM
$ARDS @BuyoutBobby @Shanenobody If Vu had any kind of ethics / belief in the company technology, he would seek a merger with a related, small biotech company, or would look to sell the whole thing on the cheap to someone else. The fact that he hasn't says a whole lot.
2 · Reply
ReturnOfEsquire
ReturnOfEsquire Mar. 15 at 1:21 AM
$ARDS
0 · Reply
Shanenobody
Shanenobody Feb. 27 at 8:39 PM
$ARDS So BuyoutBobby exactly when are you going to make sure AstraZeneca's reputation is damaged.
1 · Reply
Shanenobody
Shanenobody Feb. 27 at 8:33 PM
$ARDS
2 · Reply
BuyoutBobby
BuyoutBobby Feb. 26 at 7:15 PM
$ARDS Armistice is still holding their shares.
2 · Reply
ReturnOfEsquire
ReturnOfEsquire Feb. 21 at 2:45 AM
$ARDS @Phaaisatroll that buyout/partnership sure is taking a long time, you lying sack of turds.
1 · Reply
ReturnOfEsquire
ReturnOfEsquire Feb. 13 at 6:04 PM
$ARDS This was never about making it to market or Vu wouldn't have cut corners on P3 enrollment. This was about the grift and living off retail shareholders.
1 · Reply
ReturnOfEsquire
ReturnOfEsquire Jan. 27 at 2:36 AM
$ARDS @Phaaisatroll @Bigos Phaaisa thinking Vu will pop his stupid head in...what a delusional fool.
1 · Reply
Bigos
Bigos Jan. 15 at 7:05 PM
$ARDS Looks like nothing has to happen. They are doing nothing.
1 · Reply
Bigos
Bigos Jan. 13 at 6:38 PM
$ARDS Warum schweigt die Führung von ARDS und benachteiligt die Aktionäre?
0 · Reply